Filing Details
- Accession Number:
- 0001144204-19-018081
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-04-03 19:00:25
- Reporting Period:
- 2019-04-01
- Accepted Time:
- 2019-04-03 19:00:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1270073 | Intercept Pharmaceuticals Inc. | ICPT | Pharmaceutical Preparations (2834) | 223868459 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1559570 | David Shapiro | C/O Intercept Pharmaceuticals, Inc. 10 Hudson Yards, Floor 37 New York NY 10001 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-04-01 | 482 | $111.50 | 40,061 | No | 4 | F | Direct | |
Common Stock | Disposition | 2019-04-03 | 562 | $115.01 | 39,499 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock and restricted stock unit awards previously granted to the reporting person.
- This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.